NREP
NEW REPRESENTATIVE AT IB RECEIVED
26/09/2025
Voltar para busca
Dado oficial do USPTO
ABOMICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
27/09/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 44
Data de depósito
27/04/2022
Data de registro
30/01/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/01/2024
Última transação
27/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
FI
Examinador
GREENE, BYRON
Unidade examinadora
L70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Abomics Oy
Representantes
Lisa C. Pavento Meunier Carlin & Curfman LLC
Classificação técnica
Classes Nice
Classe 9Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable computer software for accessviewingrecordingtransmittingprocessingvisualization of medical datapharmacogenetic datamedicine data; Downloadable electronic databases containing structured medical datapharmacogenetic data and medicine datafor use with computer software; Downloadable computer software for authorizing access to databases in the fields of pharmacogenetics and pharmaceuticals; Downloadable electronic databases featuring medical data in the field of pharmacogeneticsfor use with computer software; Downloadable electronic databases featuring medical data in the field of pharmaceuticalsfor use with computer software; Downloadable computer software and applications for accessviewingrecordingtransmittingvisualization of medical datapharmacogenetic data and medicine data for use on mobile devices
Classe 44
Providing online medical record analysis services designed to provide patients and medical professionals with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms other than in the field of dentistry; Providing online medical record analysis services designed to provide patients and medical professionals online clinical reports with information about medical conditions other than in the field of dentistry; Pharmaceutical adviceproviding online pharmacogenetic reports other than in the field of dentistry; Pharmaceutical advice; pharmaceutical adviceproviding information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals; medical assistance; genetic testing for medical purposes; medical evaluation services for assessing effects and effectiveness of medical substances; Medical evaluation services for interpreting genes of patients to predict which drugs have the best opportunity for positive outcomes for patientspersonalize medication selection and treatment choices for patientsidentify potentially harmful drug reactions and calculate drug dosage adjustments for patients; medical counselling; medical information; medical analysis services relating to treatment of patients; DNA screening for medical purposes; providing information relating to medical services; medical analysis for the diagnosis and treatment of persons; medical and healthcare services related to DNAgenetics and genetic testing; medical and healthcare services related to DNAgenetics and genetic testingproviding medical information to medical professionals in the form of reports in the field of pharmaceutical-gene interactions
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
21/05/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
30/04/2024
FIMP
FINAL DISPOSITION PROCESSED
30/04/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30/04/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
30/01/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
30/01/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
27/11/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/11/2023
PUBO
PUBLISHED FOR OPPOSITION
14/11/2023
GPNX
NOTIFICATION PROCESSED BY IB
12/11/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/11/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/11/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
25/10/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
25/10/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/10/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/10/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
10/10/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/10/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/10/2023
RFNT
REFUSAL PROCESSED BY IB
24/04/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/04/2023
RFRR
REFUSAL PROCESSED BY MPU
04/04/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
16/02/2023
CNRT
NON-FINAL ACTION WRITTEN
15/02/2023
DOCK
ASSIGNED TO EXAMINER
15/02/2023
MAFR
APPLICATION FILING RECEIPT MAILED
21/06/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/06/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
10/06/2022
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
02/06/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ABOMICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.